Related Experiment Video
Updated: Aug 24, 2025

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
The effect of helix-inducing constraints and downsizing upon a transcription block survival-derived functional cJun
Andrew Brennan1, James T Leech1, Neil M Kad2
1Department of Life Sciences, University of Bath, Bath BA2 7AY, UK.
Abstract:
Inhibition of cJun is established as a promising therapeutic approach, particularly in cancer. We recently developed the "transcription block survival" (TBS) screening platform to derive functional peptide antagonists of transcription factor activity by ablating their ability to bind to cognate DNA. Using TBS, we screened a >131,000-member peptide library to select a 63-mer peptide that bound cJun and prevented 12-O-tetradecanoylphorbol-13-acetate response element (TRE) DNA binding. Iterative truncation was next combined with a systematic exploration of side-chain cyclization to derive a minimal active sequence. The resulting dual lactamized sequence was >40% smaller and retained low nM target affinity (equilibrium binding constant [K D ] = 0.2 versus 9.7 nM), with 8 residues at the acidic region required for functional antagonism. However, even modest C-terminal truncation resulted in functional loss. The peptide functionally antagonizes cJun (half-maximal inhibitory concentration [IC50] = 13 versus 45 microM) and is considerably more stable in human serum relative to its non-lactamized counterpart and HingeW.
Insights
Researchers developed a novel screening platform to identify peptide inhibitors of cJun, a key cancer target. They optimized a peptide antagonist, creating a smaller, more stable, and potent inhibitor for therapeutic development.
Area of Science:
- Molecular Biology
- Drug Discovery
- Cancer Therapeutics
Background:
- Inhibition of cJun is a promising strategy for cancer therapy.
- The transcription block survival (TBS) platform screens for peptide antagonists of transcription factors.
Purpose of the Study:
- To develop functional peptide antagonists of cJun DNA binding using the TBS platform.
- To derive a minimal active peptide sequence with enhanced stability and potency.
Main Methods:
- Screening a large peptide library (>131,000 members) using the TBS platform.
- Iterative truncation and side-chain cyclization to optimize peptide sequence.
- Characterization of binding affinity (K_D) and functional antagonism (IC50).
Main Results:
- A 63-mer peptide antagonist of cJun-TRE DNA binding was identified.
- A smaller, dual lactamized peptide retained low nM affinity (K_D = 0.2 nM) and functional antagonism (IC50 = 13 µM).
- The optimized peptide demonstrated increased stability in human serum compared to its non-lactamized form.
Conclusions:
- The TBS platform effectively identifies functional peptide antagonists.
- Optimized peptide antagonists of cJun show potential for cancer therapy due to enhanced potency and stability.
- Specific residues in the acidic region are crucial for functional antagonism.
More Related Videos
10:46Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
Published on: June 2, 2018
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Cooperative Binding of Transcription Regulators
Cis-regulatory Sequences
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Co-activators and Co-repressors